Progyny, Inc. (PGNY) — Fair Value Analysis
Base-case fair value (P50): $19.98 · Current price: $19.16 · Verdict: Fairly Valued
The Verdict on PGNY
PROGYNY INC (PGNY) is currently deemed Fairly Valued, according to our Monte Carlo simulations. The stock trades at $19.16, while our median fair value (P50) is calculated at $19.98, representing a potential +4.3% upside from its current price. This close alignment between the current market price and the probabilistic fair value suggests that the market is largely reflecting PGNY's intrinsic worth based on present fundamentals and a wide array of simulated future scenarios.
Based on our analysis, PGNY’s current price of $19.16 sits comfortably within the distribution of fair values generated by thousands of Monte Carlo simulations. The proximity to the P50 of $19.98 underscores its "Fairly Valued" assessment, indicating that while there's a modest +4.3% implied upside, it’s not significantly discounted or overextended at this point. This provides a clear, data-driven perspective for investors assessing the stock.
How PGNY stacks up against peers
PGNY earns a strong quality tier rating, a critical factor in its "Fairly Valued" assessment. This designation indicates robust operational and financial health when compared to its sector peers. A strong quality tier suggests that PROGYNY INC is well-positioned, exhibiting fundamental resilience and efficiency. This strong standing, coupled with its current price of $19.16 and a P50 of $19.98, reinforces the market's rational pricing of the asset given its underlying strengths.
What this means for investors
For investors, PGNY’s "Fairly Valued" status, combined with a strong quality tier and a +4.3% upside to its median fair value of $19.98, suggests a balanced risk-reward profile. While the current price of $19.16 doesn't present a deep discount, the underlying strength supports its valuation. Understanding the full spectrum of potential outcomes—from a downside scenario to a bull case—is key to informed decision-making. Sign up for FairCurve to see the full bear/bull distribution and track PGNY's fair value as new fundamentals are released.
Frequently Asked Questions
Is PGNY overvalued or undervalued right now?
PROGYNY INC (PGNY) is currently deemed Fairly Valued. Its current price of $19.16 is closely aligned with our Monte Carlo median fair value (P50) of $19.98, implying a modest +4.3% upside.
What is the bear case and bull case for PGNY?
The full Monte Carlo distribution, including our bear (P10) and bull (P90) target prices, along with the probability of upside, is available with a free FairCurve account.
How does FairCurve calculate PGNY's fair value?
FairCurve calculates PGNY's fair value using advanced Monte Carlo simulations that model thousands of forward scenarios, capturing the full range of potential outcomes for the company.
How can I track PGNY's fair value as it changes?
You can add PROGYNY INC (PGNY) to your free FairCurve watchlist for daily fair-value updates and instant re-valuation whenever new earnings or significant fundamental data are released.